Cited by 77Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder ResearchSchizophrenia research and treatment

Time after time: failure to identify and support females with ADHD – a Swedish population register study

Open access
Skoglund, Charlotte, Sundström Poromaa, Inger, Leksell, Daniel, Ekholm Selling, Katarina, Cars, Thomas, Giacobini, Maibritt, Young, Susan, Kopp Kallner, Helena·2024·Journal of Child Psychology and Psychiatry

Abstract

Background: Attention deficit hyperactivity disorder (ADHD) is associated with risk taking and negative health‐related outcomes across the lifespan. Due to delay in referral and diagnostics, young females with ADHD may not be identified, nor appropriately supported by adequate interventions. Methods: A total of 85,330 individuals with ADHD, all of whom were residents in Stockholm County between January 01, 2011, and December 31, 2021, were included as participants in this population‐based, cross‐sectional cohort study. Population controls ( n = 426,626) were matched by age, sex, and socioeconomic status (SES). Data was obtained from Regional Healthcare Data Warehouse of Region Stockholm (VAL) in Stockholm County. Exposure was ADHD‐index, defined as the first record of either ICD‐10 F90 diagnosis and/or ATC‐code for stimulant or non‐stimulant ADHD‐medication during the study period. Primary outcome was age at ADHD‐index. Secondary outcome measures were psychiatric comorbidity, pharmacological treatment, and health care utilization, prior to and after ADHD‐index. Results: Females were older at ADHD‐index (23.5 years, SD 13.8) compared to males (19.6 years, SD 13.9, 95% CI of difference 3.74–4.11). Overall, females with ADHD showed higher rates of psychiatric comorbidity, pharmacological treatment, and health care utilization, compared to males with ADHD and female controls. Conclusions: Females with ADHD receive diagnosis and treatment for ADHD approximately 4 years later than males. They have a higher burden of comorbid psychiatric conditions and health care utilization, compared to males with ADHD and female controls, both prior to and after ADHD‐index. To prevent long‐term adverse consequences for females with ADHD, methods, and tools for early diagnosis and treatments that mitigate personal suffering and societal burden are warranted.

Integrity signals

Registry

Crossref · 10.1111/jcpp.13920

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Skoglund, C., Sundström Poromaa, I., Leksell, D., Ekholm Selling, K., Cars, T., Giacobini, M., Young, S., & Kopp Kallner, H.
Affiliations
  • Uppsala University (SE)
  • Department of Women's and Children's Health Uppsala University Uppsala Sweden
  • Smart Psykiatri AB Stockholm Sweden
  • Sence Research AB Uppsala Sweden
  • Karolinska Institutet (SE)
  • Reykjavík University (IS)
  • Department of Clinical Sciences at Danderyd Hospital Karolinska Institutet Stockholm Sweden
Corresponding author
Skoglund, Charlotte
Venue
Journal of Child Psychology and Psychiatry
Publisher
Wiley
Published
2023-11-28
Volume
65
Issue
6
Pages
832-844
ISSN
  • 0021-9630 (ISSN-L)
  • 1469-7610
OpenAlex
W4389109678
Cited by
77
References
41
Citations by year
2026: 41 · 2025: 27 · 2024: 9
FWCI
15.61
Type
journal article
Language
en
Open access
Locations
  • Journal of Child Psychology and Psychiatry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Opin vísindi (Opin vísindi) (submittedVersion, cc-by-nc-sa)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
Funders
  • Eli Lilly and Company
  • Gedeon Richter
  • Uppsala Universitet
  • H. Lundbeck A/S
  • UCB Pharma
  • Cilag
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
attention deficit hyperactivity disorder, delayed diagnosis, age at diagnosis, psychiatric comorbidity, ADHD medication, health care utilization, sex differences, early diagnosis, Stockholm County
MeSH terms
Adolescent, Adult, Attention Deficit Disorder with Hyperactivity, Child, Cross-Sectional Studies, Female, Humans, Male, Patient Acceptance of Health Care, Registries, Sex Factors, Sweden, Comorbidity, Young Adult, Delayed Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review